-
1
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674.
-
(2011)
Cell.
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
2
-
-
0035474473
-
Signaling via Shc family adapter proteins
-
Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene. 2001; 20: 6322-6330.
-
(2001)
Oncogene.
, vol.20
, pp. 6322-6330
-
-
Ravichandran, K.S.1
-
3
-
-
0026777369
-
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
-
Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Pawson T, Pelicci PG. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 1992; 70: 93-104.
-
(1992)
Cell.
, vol.70
, pp. 93-104
-
-
Pelicci, G.1
Lanfrancone, L.2
Grignani, F.3
Mcglade, J.4
Cavallo, F.5
Forni, G.6
Nicoletti, I.7
Pawson, T.8
Pelicci, P.G.9
-
4
-
-
0027165366
-
Shc products are substrates of erbB-2 kinase
-
Segatto O, Pelicci G, Giuli S, Digiesi G, Di Fiore PP, McGlade J, Pawson T, Pelicci PG. Shc products are substrates of erbB-2 kinase. Oncogene. 1993; 8: 2105-2112.
-
(1993)
Oncogene.
, vol.8
, pp. 2105-2112
-
-
Segatto, O.1
Pelicci, G.2
Giuli, S.3
Digiesi, G.4
Di Fiore, P.P.5
McGlade, J.6
Pawson, T.7
Pelicci, P.G.8
-
5
-
-
0027466903
-
Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins
-
Pronk GJ, McGlade J, Pelicci G, Pawson T, Bos JL. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J Biol Chem. 1993; 268: 5748-5753.
-
(1993)
J Biol Chem.
, vol.268
, pp. 5748-5753
-
-
Pronk, G.J.1
Mcglade, J.2
Pelicci, G.3
Pawson, T.4
Bos, J.L.5
-
6
-
-
40949130063
-
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
-
Ursini-Siegel J, Hardy WR, Zuo D, Lam SH, Sanguin-Gendreau V, Cardiff RD, Pawson T, Muller WJ. ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J. 2008; 27: 910-920.
-
(2008)
EMBO J.
, vol.27
, pp. 910-920
-
-
Ursini-Siegel, J.1
Hardy, W.R.2
Zuo, D.3
Lam, S.H.4
Sanguin-Gendreau, V.5
Cardiff, R.D.6
Pawson, T.7
Muller, W.J.8
-
7
-
-
43249109660
-
Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion
-
Northey JJ, Chmielecki J, Ngan E, Russo C, Annis MG, Muller WJ, et al. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Mol Cell Biol. 2008; 28: 3162-3176.
-
(2008)
Mol Cell Biol.
, vol.28
, pp. 3162-3176
-
-
Northey, J.J.1
Chmielecki, J.2
Ngan, E.3
Russo, C.4
Annis, M.G.5
Muller, W.J.6
-
8
-
-
58149510524
-
Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium
-
Honda H, Barrueto FF, Gogusev J, Im DD, Morin PJ. Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Reprod Biol Endocrinol. 2008; 6: 59-71.
-
(2008)
Possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Reprod Biol Endocrinol.
, vol.6
, pp. 59-71
-
-
Honda, H.1
Barrueto, F.F.2
Gogusev, J.3
Im, D.D.4
Morin, P.J.5
-
9
-
-
0031056755
-
Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway
-
Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G, Pawson T, Di Fiore PP, Lanfrancone L, Pelicci PG. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 1997; 16: 706-716.
-
(1997)
EMBO J.
, vol.16
, pp. 706-716
-
-
Migliaccio, E.1
Mele, S.2
Salcini, A.E.3
Pelicci, G.4
Lai, K.M.5
Superti-Furga, G.6
Pawson, T.7
Di Fiore, P.P.8
Lanfrancone, L.9
Pelicci, P.G.10
-
10
-
-
65549123630
-
A novel role of Shc adaptor proteins in steroid hormone-regulated cancers
-
Alam SM, Rajendran M, Ouyang S, Veeramani S, Zhang L, Lin MF. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers. Endocr Relat Cancer. 2009; 16: 1-16.
-
(2009)
Endocr Relat Cancer.
, vol.16
, pp. 1-16
-
-
Alam, S.M.1
Rajendran, M.2
Ouyang, S.3
Veeramani, S.4
Zhang, L.5
Lin, M.F.6
-
11
-
-
0033581704
-
The p66shc adaptor protein controls oxidative stress response and life span in mammals
-
Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 1999; 402: 309-313.
-
(1999)
Nature.
, vol.402
, pp. 309-313
-
-
Migliaccio, E.1
Giorgio, M.2
Mele, S.3
Pelicci, G.4
Reboldi, P.5
Pandolfi, P.P.6
Lanfrancone, L.7
Pelicci, P.G.8
-
12
-
-
0027934261
-
Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins
-
Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene. 1994; 9: 2827-2836.
-
(1994)
Oncogene.
, vol.9
, pp. 2827-2836
-
-
Salcini, A.E.1
McGlade, J.2
Pelicci, G.3
Nicoletti, I.4
Pawson, T.5
Pelicci, P.G.6
-
13
-
-
10744225848
-
p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells
-
Pacini S, Pellegrini M, Migliaccio E, Patrussi L, Ulivieri C, Ventura A, Carraro F, Naldini A, Lanfrancone L, Pelicci P, Baldari CT. p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells. Mol Cell Biol. 2004; 24: 1747-1757.
-
(2004)
Mol Cell Biol.
, vol.24
, pp. 1747-1757
-
-
Pacini, S.1
Pellegrini, M.2
Migliaccio, E.3
Patrussi, L.4
Ulivieri, C.5
Ventura, A.6
Carraro, F.7
Naldini, A.8
Lanfrancone, L.9
Pelicci, P.10
Baldari, C.T.11
-
14
-
-
40549146557
-
p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria
-
Pinton P, Rizzuto R. p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria. Cell Cycle. 2008; 7: 304-308.
-
(2008)
Cell Cycle.
, vol.7
, pp. 304-308
-
-
Pinton, P.1
Rizzuto, R.2
-
15
-
-
77957982069
-
p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior
-
Ma Z, Liu Z, Wu RF, Terada LS. p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior. Oncogene. 2010; 29: 5559-5567.
-
(2010)
Oncogene.
, vol.29
, pp. 5559-5567
-
-
Ma, Z.1
Liu, Z.2
Wu, R.F.3
Terada, L.S.4
-
16
-
-
27944483366
-
Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells
-
Veeramani S, Igawa T, Yuan TC, Lin FF, Lee MS, Lin JS, Johansson SL, Lin MF. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells. Oncogene. 2005; 24: 7203-7212.
-
(2005)
Oncogene.
, vol.24
, pp. 7203-7212
-
-
Veeramani, S.1
Igawa, T.2
Yuan, T.C.3
Lin, F.F.4
Lee, M.S.5
Lin, J.S.6
Johansson, S.L.7
Lin, M.F.8
-
17
-
-
0034099236
-
Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential
-
Jackson JG, Yoneda T, Clark GM, Yee D. Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res. 2000: 6: 1135-1139.
-
(2000)
Clin Cancer Res.
, vol.6
, pp. 1135-1139
-
-
Jackson, J.G.1
Yoneda, T.2
Clark, G.M.3
Yee, D.4
-
18
-
-
0346024127
-
p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas
-
Lee MS, Igawa T, Chen SJ, Van Bemmel D, Lin JS, Lin FF, Johansson SL, Christman JK, Lin MF. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas. Int J Cancer. 2004; 108: 672-678.
-
(2004)
Int J Cancer.
, vol.108
, pp. 672-678
-
-
Lee, M.S.1
Igawa, T.2
Chen, S.J.3
Van Bemmel, D.4
Lin, J.S.5
Lin, F.F.6
Johansson, S.L.7
Christman, J.K.8
Lin, M.F.9
-
19
-
-
77349100142
-
p66Shc-a longevity redox protein in human prostate cancer progression and metastasis: p66Shc in cancer progression and metastasis
-
Rajendran M, Thomes P, Zhang L, Veeramani S, Lin MF. p66Shc-a longevity redox protein in human prostate cancer progression and metastasis: p66Shc in cancer progression and metastasis. Cancer Metastasis Rev. 2010; 29: 207-222
-
(2010)
Cancer Metastasis Rev.
, vol.29
, pp. 207-222
-
-
Rajendran, M.1
Thomes, P.2
Zhang, L.3
Veeramani, S.4
Lin, M.F.5
-
20
-
-
0032188824
-
A novel candidate oncogene, MCT-1, is involved in cell cycle progression
-
Prosniak M, Dierov J, Okami K, Tilton B, Jameson B, Sawaya BE, Gartenhaus RB. A novel candidate oncogene, MCT-1, is involved in cell cycle progression. Cancer Res. 1998; 58: 4233-4237.
-
(1998)
Cancer Res.
, vol.58
, pp. 4233-4237
-
-
Prosniak, M.1
Dierov, J.2
Okami, K.3
Tilton, B.4
Jameson, B.5
Sawaya, B.E.6
Gartenhaus, R.B.7
-
21
-
-
0033567844
-
Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1
-
Dierov J, Prosniak M, Gallia G, Gartenhaus RB. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1. J Cell Biochem. 1999; 74: 544-550.
-
(1999)
J Cell Biochem.
, vol.74
, pp. 544-550
-
-
Dierov, J.1
Prosniak, M.2
Gallia, G.3
Gartenhaus, R.B.4
-
22
-
-
0038240400
-
Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies
-
Shi B, Hsu HL, Evens AM, Gordon LI, Gartenhaus RB. Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies. Blood. 2003; 102: 297-302.
-
(2003)
Blood.
, vol.102
, pp. 297-302
-
-
Shi, B.1
Hsu, H.L.2
Evens, A.M.3
Gordon, L.I.4
Gartenhaus, R.B.5
-
23
-
-
34147172856
-
Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage
-
Nandi S, Reinert LS, Hachem A, Mazan-Mamczarz K, Hagner P, He H, Gartenhaus RB. Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage. Oncogene. 2007; 26: 2283-2289.
-
(2007)
Oncogene.
, vol.26
, pp. 2283-2289
-
-
Nandi, S.1
Reinert, L.S.2
Hachem, A.3
Mazan-Mamczarz, K.4
Hagner, P.5
He, H.6
Gartenhaus, R.B.7
-
24
-
-
84863231362
-
The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities
-
Shih HJ, Chu KL, Wu MH, Wu PH, Chang WW, Chu JS, Wang LH, Takeuchi H, Ouchi T, Hsu HL. The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities. Cell Cycle. 2012; 11: 934-952.
-
(2012)
Cell Cycle.
, vol.11
, pp. 934-952
-
-
Shih, H.J.1
Chu, K.L.2
Wu, M.H.3
Wu, P.H.4
Chang, W.W.5
Chu, J.S.6
Wang, L.H.7
Takeuchi, H.8
Ouchi, T.9
Hsu, H.L.10
-
25
-
-
23744512515
-
The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells
-
Hsu HL, Shi B, Gartenhaus RB. The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells. Oncogene. 2005; 24: 4956-4964.
-
(2005)
Oncogene.
, vol.24
, pp. 4956-4964
-
-
Hsu, H.L.1
Shi, B.2
Gartenhaus, R.B.3
-
26
-
-
34547842074
-
MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage
-
Hsu HL, Choy CO, Kasiappan R, Shih HJ, Sawyer JR, Shu CL, Chu KL, Chen YR, Hsu HF, Gartenhaus RB. MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage. DNA Repair (Amst). 2007; 6: 1319-1332.
-
(2007)
DNA Repair (Amst).
, vol.6
, pp. 1319-1332
-
-
Hsu, H.L.1
Choy, C.O.2
Kasiappan, R.3
Shih, H.J.4
Sawyer, J.R.5
Shu, C.L.6
Chu, K.L.7
Chen, Y.R.8
Hsu, H.F.9
Gartenhaus, R.B.10
-
27
-
-
65549131527
-
Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity
-
Kasiappan R, Shih HJ, Chu KL, Chen WT, Liu HP, Huang SF, Choy CO, Shu CL, Din R, Chu JS, Hsu HL. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity. Mol Cancer Res. 2009; 7: 536-548.
-
(2009)
Mol Cancer Res.
, vol.7
, pp. 536-548
-
-
Kasiappan, R.1
Shih, H.J.2
Chu, K.L.3
Chen, W.T.4
Liu, H.P.5
Huang, S.F.6
Choy, C.O.7
Shu, C.L.8
Din, R.9
Chu, J.S.10
Hsu, H.L.11
-
28
-
-
78649760150
-
The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
-
Kasiappan R, Shih HJ, Wu MH, Choy C, Lin TD, Chen L, Hsu HL. The antagonism between MCT-1 and p53 affects the tumorigenic outcomes. Mol Cancer. 2010; 9: 311-327.
-
(2010)
Mol Cancer.
, vol.9
, pp. 311-327
-
-
Kasiappan, R.1
Shih, H.J.2
Wu, M.H.3
Choy, C.4
Lin, T.D.5
Chen, L.6
Hsu, H.L.7
-
29
-
-
54249097458
-
Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach
-
Mazan-Mamczarz K, Hagner PR, Dai B, Wood WH, Zhang Y, Becker KG, Liu Z, Gartenhaus RB. Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. Cancer Res. 2008; 68: 7730-7735.
-
(2008)
Cancer Res.
, vol.68
, pp. 7730-7735
-
-
Mazan-Mamczarz, K.1
Hagner, P.R.2
Dai, B.3
Wood, W.H.4
Zhang, Y.5
Becker, K.G.6
Liu, Z.7
Gartenhaus, R.B.8
-
30
-
-
28244452916
-
MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis
-
Levenson AS, Thurn KE Simons LA, Veliceasa D, Jarrett J, Osipo C, Jordan VC, Volpert OV, Satcher RL Jr, Gartenhaus RB. MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis. Cancer Res. 2005; 65: 10651-10656.
-
(2005)
Cancer Res.
, vol.65
, pp. 10651-10656
-
-
Levenson, A.S.1
Thurn, K.E.2
Simons, L.A.3
Veliceasa, D.4
Jarrett, J.5
Osipo, C.6
Jordan, V.C.7
Volpert, O.V.8
Satcher Jr., R.L.9
Gartenhaus, R.B.10
-
31
-
-
54049135560
-
Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype
-
Mazan-Mamczarz K Hagner PR, Corl S, Srikantan S, Wood WH, Becker KG, Gorospe M, Keene JD, Levenson AS, Gartenhaus RB. Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene. 2008; 27: 6151-6163.
-
(2008)
Oncogene.
, vol.27
, pp. 6151-6163
-
-
Mazan-Mamczarz, K.1
Hagner, P.R.2
Corl, S.3
Srikantan, S.4
Wood, W.H.5
Becker, K.G.6
Gorospe, M.7
Keene, J.D.8
Levenson, A.S.9
Gartenhaus, R.B.10
-
32
-
-
0033587009
-
Sustained MAP kinase activation is required for the expression of Cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells
-
Balmanno K Cook SJ. Sustained MAP kinase activation is required for the expression of Cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene. 1999; 18: 3085-3097.
-
(1999)
Oncogene.
, vol.18
, pp. 3085-3097
-
-
Balmanno, K.1
Cook, S.J.2
-
33
-
-
0029786329
-
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
-
Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem. 1996; 271: 20608-20616.
-
(1996)
J Biol Chem.
, vol.271
, pp. 20608-20616
-
-
Lavoie, J.N.1
L'allemain, G.2
Brunet, A.3
Muller, R.4
Pouyssegur, J.5
-
34
-
-
20444482051
-
MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm
-
Phelps M, Phillips A, Darley M, Blaydes JP. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm. J Biol Chem. 2005;280:16651-8.
-
(2005)
J Biol Chem.
, vol.280
, pp. 16651-16658
-
-
Phelps, M.1
Phillips, A.2
Darley, M.3
Blaydes, J.P.4
-
35
-
-
0032575750
-
Caspases: enemies within
-
Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998; 281: 1312-1316.
-
(1998)
Science.
, vol.281
, pp. 1312-1316
-
-
Thornberry, N.A.1
Lazebnik, Y.2
-
36
-
-
0035020420
-
Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis
-
Byun Y, Chen F, Chang R, Trivedi M, Green KJ, Cryns VL. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ. 2001; 8: 443-450.
-
(2001)
Cell Death Differ.
, vol.8
, pp. 443-450
-
-
Byun, Y.1
Chen, F.2
Chang, R.3
Trivedi, M.4
Green, K.J.5
Cryns, V.L.6
-
37
-
-
80052267874
-
Vimentin in cancer and its potential as a molecular target for cancer therapy
-
Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011; 68: 3033-3046.
-
(2011)
Cell Mol Life Sci.
, vol.68
, pp. 3033-3046
-
-
Satelli, A.1
Li, S.2
-
38
-
-
34247147681
-
Caspase proteolysis of the integrin beta4 subunit disrupts hemidesmosome assembly, promotes apoptosis, and inhibits cell migration
-
Werner ME, Chen F, Moyano JV, Yehiely F, Jones JC, Cryns VL. Caspase proteolysis of the integrin beta4 subunit disrupts hemidesmosome assembly, promotes apoptosis, and inhibits cell migration. J Biol Chem. 2007; 282: 5560-5569.
-
(2007)
J Biol Chem.
, vol.282
, pp. 5560-5569
-
-
Werner, M.E.1
Chen, F.2
Moyano, J.V.3
Yehiely, F.4
Jones, J.C.5
Cryns, V.L.6
-
39
-
-
0037059796
-
ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status
-
Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Kim JH, Yoo YJ, Bang OS, Kang SS, Chun JS. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem. 2002; 277: 1332-1339.
-
(2002)
J Biol Chem.
, vol.277
, pp. 1332-1339
-
-
Kim, S.J.1
Ju, J.W.2
Oh, C.D.3
Yoon, Y.M.4
Song, W.K.5
Kim, J.H.6
Yoo, Y.J.7
Bang, O.S.8
Kang, S.S.9
Chun, J.S.10
-
40
-
-
39449086763
-
Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity
-
Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ. 2008; 15: 530-544.
-
(2008)
Cell Death Differ.
, vol.15
, pp. 530-544
-
-
Yang, C.1
Kaushal, V.2
Haun, R.S.3
Seth, R.4
Shah, S.V.5
Kaushal, G.P.6
-
41
-
-
34548313955
-
Clonogenic assay of cells in vitro
-
Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006; 1: 2315-2319.
-
(2006)
Nat Protoc.
, vol.1
, pp. 2315-2319
-
-
Franken, N.A.1
Rodermond, H.M.2
Stap, J.3
Haveman, J.4
van Bree, C.5
-
42
-
-
0027255417
-
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis
-
Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993; 53: 3976-3985.
-
(1993)
Cancer Res.
, vol.53
, pp. 3976-3985
-
-
Kaufmann, S.H.1
Desnoyers, S.2
Ottaviano, Y.3
Davidson, N.E.4
Poirier, G.G.5
-
43
-
-
0030002801
-
Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.
-
Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 1996; 315: 21-24.
-
(1996)
Biochem J.
, vol.315
, pp. 21-24
-
-
Slee, E.A.1
Zhu, H.2
Chow, S.C.3
Macfarlane, M.4
Nicholson, D.W.5
Cohen, G.M.6
-
45
-
-
33646394582
-
Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death
-
Swift LP, Rephaeli A, Nudelman A, Phillips DR, Cutts SM. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death. Cancer Res. 2006; 66: 4863-4871.
-
(2006)
Cancer Res.
, vol.66
, pp. 4863-4871
-
-
Swift, L.P.1
Rephaeli, A.2
Nudelman, A.3
Phillips, D.R.4
Cutts, S.M.5
-
46
-
-
0022340594
-
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
-
Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 1985; 260: 14873-14878.
-
(1985)
J Biol Chem.
, vol.260
, pp. 14873-14878
-
-
Hsiang, Y.H.1
Hertzberg, R.2
Hecht, S.3
Liu, L.F.4
-
47
-
-
0028912067
-
Successful local regional therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts
-
Pratesi G, Tortoreto M, Corti C, Giardini R, Zunino F. Successful local regional therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts. Br J Cancer. 1995; 71: 525-528.
-
(1995)
Br J Cancer.
, vol.71
, pp. 525-528
-
-
Pratesi, G.1
Tortoreto, M.2
Corti, C.3
Giardini, R.4
Zunino, F.5
-
48
-
-
0034564145
-
Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer
-
Saltz L. Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer. Oncology. 2000; 14: 47-50.
-
(2000)
Oncology.
, vol.14
, pp. 47-50
-
-
Saltz, L.1
-
49
-
-
0037151066
-
The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter
-
Ventura A, Luzi L, Pacini S, Baldari CT, Pelicci PG. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J Biol Chem. 2002; 277: 22370-22376.
-
(2002)
J Biol Chem.
, vol.277
, pp. 22370-22376
-
-
Ventura, A.1
Luzi, L.2
Pacini, S.3
Baldari, C.T.4
Pelicci, P.G.5
-
50
-
-
13844280115
-
p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of CyclinB1 transcription
-
Innocente SA, Lee JM. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of CyclinB1 transcription. FEBS Lett. 2005; 579: 1001-1007.
-
(2005)
FEBS Lett.
, vol.579
, pp. 1001-1007
-
-
Innocente, S.A.1
Lee, J.M.2
-
51
-
-
33749489960
-
MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles
-
Reinert LS, Shi B, Nandi S, Mazan-Mamczarz K, Vitolo M, Bachman KE, He H, Gartenhaus RB. MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles. Cancer Res. 2006; 66: 8994-9001.
-
(2006)
Cancer Res.
, vol.66
, pp. 8994-9001
-
-
Reinert, L.S.1
Shi, B.2
Nandi, S.3
Mazan-Mamczarz, K.4
Vitolo, M.5
Bachman, K.E.6
He, H.7
Gartenhaus, R.B.8
-
52
-
-
77955862748
-
Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling
-
Skabkin MA, Skabkina OV, Dhote V, Komar AA, Hellen CU, Pestova TV. Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling. Genes Dev. 2010; 24: 1787-1801.
-
(2010)
Genes Dev.
, vol.24
, pp. 1787-1801
-
-
Skabkin, M.A.1
Skabkina, O.V.2
Dhote, V.3
Komar, A.A.4
Hellen, C.U.5
Pestova, T.V.6
-
53
-
-
33847328289
-
The Bcl-2 apoptotic switch in cancer development and therapy
-
Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007; 26: 1324-1337.
-
(2007)
Oncogene.
, vol.26
, pp. 1324-1337
-
-
Adams, J.M.1
Cory, S.2
-
54
-
-
68049143304
-
Apoptosis and cancer: mutations within caspase genes
-
Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, Los M. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009; 46: 497-510.
-
(2009)
J Med Genet.
, vol.46
, pp. 497-510
-
-
Ghavami, S.1
Hashemi, M.2
Ande, S.R.3
Yeganeh, B.4
Xiao, W.5
Eshraghi, M.6
Bus, C.J.7
Kadkhoda, K.8
Wiechec, E.9
Halayko, A.J.10
Los, M.11
-
55
-
-
70350565471
-
p53-a Jack of all trades but master of none
-
Junttila MR, Evan GI. p53-a Jack of all trades but master of none. Nat Rev Cancer. 2009; 9: 821-829.
-
(2009)
Nat Rev Cancer.
, vol.9
, pp. 821-829
-
-
Junttila, M.R.1
Evan, G.I.2
-
56
-
-
33746764457
-
Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis
-
Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell. 2006; 126: 489-502.
-
(2006)
Cell.
, vol.126
, pp. 489-502
-
-
Guo, W.1
Pylayeva, Y.2
Pepe, A.3
Yoshioka, T.4
Muller, W.J.5
Inghirami, G.6
Giancotti, F.G.7
-
57
-
-
7944224012
-
Integrin beta4 signaling promotes tumor angiogenesis
-
Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, Giancotti FG. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell. 2004; 6: 471-483.
-
(2004)
Cancer Cell.
, vol.6
, pp. 471-483
-
-
Nikolopoulos, S.N.1
Blaikie, P.2
Yoshioka, T.3
Guo, W.4
Giancotti, F.G.5
-
58
-
-
34748863597
-
Targeting integrin beta4 for cancer and anti-angiogenic therapy
-
Giancotti FG. Targeting integrin beta4 for cancer and anti-angiogenic therapy. Trends Pharmacol Sci. 2007; 28: 506-511.
-
(2007)
Trends Pharmacol Sci.
, vol.28
, pp. 506-511
-
-
Giancotti, F.G.1
-
59
-
-
0032880670
-
Selective GRB2 SH2 inhibitors as anti-Ras therapy
-
Gay B, Suarez S, Caravatti G, Furet P, Meyer T, Schoepfer J. Selective GRB2 SH2 inhibitors as anti-Ras therapy. Int J Cancer. 1999; 83: 235-241.
-
(1999)
Int J Cancer.
, vol.83
, pp. 235-241
-
-
Gay, B.1
Suarez, S.2
Caravatti, G.3
Furet, P.4
Meyer, T.5
Schoepfer, J.6
-
60
-
-
0030868695
-
Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide
-
Williams EJ, Dunican DJ, Green PJ, Howell FV, Derossi D, Walsh FS, Doherty P. Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide. J Biol Chem. 1997; 272: 22349-22354.
-
(1997)
J Biol Chem.
, vol.272
, pp. 22349-22354
-
-
Williams, E.J.1
Dunican, D.J.2
Green, P.J.3
Howell, F.V.4
Derossi, D.5
Walsh, F.S.6
Doherty, P.7
-
61
-
-
27644534154
-
Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice
-
Kim HK, Jeong MJ, Kong MY, Han MY, Son KH, Kim HM, Hong SH, Kwon BM. Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice. Life Sci. 2005; 78: 321-328 Kim HK, Jeong MJ, Kong MY, Han MY, Son KH, Kim HM, Hong SH, Kwon BM. Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice. Life Sci. 2005; 78: 321-328.
-
(2005)
Life Sci.
, vol.78
, pp. 321-328
-
-
Kim, H.K.1
Jeong, M.J.2
Kong, M.Y.3
Han, M.Y.4
Son, K.H.5
Kim, H.M.6
Hong, S.H.7
Kwon, B.M.8
|